RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

70 hedge funds and large institutions have $89.1M invested in Regulus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 8 closing their positions.

Holders
70
Holders Change
+7
Holders Change %
+11.11%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
20
Reduced
12
Closed
8
Calls
$195K
Puts
$87K
Net Calls
+$108K
Net Calls Change
-$102K

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$3.38M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$1.4M
3
Northern Trust
3
Northern Trust
Illinois
$781K
4
TD Asset Management
4
TD Asset Management
Ontario, Canada
$486K
5
Manulife (Manufacturers Life Insurance)
5
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$204K

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$1.2M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$515K
3
OM
3
Opaleye Management
Massachusetts
$840K
4
ECM
4
ExodusPoint Capital Management
New York
$0
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
76
Simplex Trading
Illinois
– -$6K -3,622 Closed
PA
77
Parallel Advisors
California
– -$18 -10 Closed
1 2 3
4